Overview of Hasta la victoria, quizás: Cuba’s broken economy
This episode of The Intelligence (The Economist) centers on Cuba’s deepening economic crisis after recent U.S. pressure, and pairs that main story with two shorter features: an investigation of the booming, unregulated online peptide market (health/wellness trend), and an obituary/profile of Chuck Norris. The Cuba report — an interview with bureau chief Sarah Burke — is the episode’s focus: it traces how decades of state control and recent U.S. actions (notably cutting Cuba’s access to subsidized Venezuelan oil and other dollar sources) have pushed the island toward paralysis, and considers likely political and humanitarian outcomes.
Cuba’s broken economy — main segment
What happened
- Recent U.S. pressure (part of the Trump-era campaign to squeeze Cuba) sharply reduced Cuba’s access to subsidized oil from Venezuela and discouraged third countries from supplying fuel. The result: severe fuel shortages, power cuts, grounded tourist flights and empty hotels.
- The U.S. has also targeted other dollar-earning streams (for example restrictions around Cuban medical missions abroad and barriers to remittances/investment), further cutting government revenues.
Structural problems that predate the recent squeeze
- Cuba’s economy has long been inefficient and heavily state-controlled. After the Soviet bloc collapse it evolved into a hybrid system: limited private activity exists but the state retains planning control, ownership of firms, and price-setting.
- Chronic misallocation: example given — sugar exports fell ~90% between 1990 and 2010 while the state continued to control key sectors.
- The government’s monetary and fiscal management has been weak; reforms have been partial and insufficient.
Immediate consequences for ordinary Cubans
- Longer queues, fuel shortages, reduced hospital services, frequent blackouts, and empty state-run shops.
- Worsened purchasing power: already-low monthly salaries buy even less.
- Protests have occurred but fear of reprisals and demographic shifts (many younger people have emigrated) limit sustained street mobilization.
Political dynamics and possible outcomes
- U.S. aim appears to be to force economic concessions: restructuring state enterprises, opening opportunities for U.S. businesses, and creating a more credible monetary system — in exchange for relief.
- Talks between Cuba and the U.S. reportedly include high-level Cuban figures (mention of Raúl Castro being involved even if not formally in office).
- Two likely patterns discussed:
- A negotiated economic opening that preserves the Castro family’s influence (a Venezuela-like managed transition).
- Or prolonged hardship with limited political change, as the regime may try to “kick the can down the road.”
- Cubans’ preferences are mixed: many want economic relief and a negotiated transition rather than chaotic collapse, but hope for political change is fading for some.
Key takeaways on Cuba
- The recent U.S. measures have intensified an already fragile system and are producing acute humanitarian pressure.
- Structural reform would be needed to stabilize the economy — but reforms that leave the ruling elite intact may not satisfy those who want political change.
- The immediate losers are ordinary Cubans; the long-term political outcome remains uncertain.
Peptides and the unregulated wellness market — second segment
What are people buying?
- Peptides are short chains of amino acids (biologically active molecules). The term online has ballooned into a wide category of unregulated products marketed for muscle growth, recovery, skin, cognition, weight loss, etc.
- Example highlighted: BPC-157 — marketed as part of a “Wolverine stack” that allegedly boosts recovery and tissue repair.
How people access them
- Widely available online from dozens of vendors who sell “research chemicals” with next-day delivery, syringes, and how-to videos. Products are often labeled “not for human consumption” to skirt regulation.
Risks and problems
- Purity and labeling: tests have found contaminants (reports of unexpected compounds, including illicit drugs and other chemicals).
- Unknown physiological risks: peptides can be biologically active (some are related to real drugs like insulin or GLP-1 agonists), but clinical safety, dosing, long-term side effects (e.g., cancer risk from stimulating blood-vessel growth) are largely unknown.
- False confidence: easy access plus snippets of scientific literature or influencer endorsements lead to “bro science” or “biohacking” claims that outpace evidence.
- Clinical trials and regulation exist for a reason: to balance benefit vs. harm — skipping that process is risky.
Regulatory response and landscape
- Mixed approaches: some U.S. moves to allow compounding pharmacies to supply certain peptides; other countries cracking down on manufacturers and websites.
- Social media marketing remains largely unchecked; influencers normalize use.
- Experts argue for better research pathways and harm-reduction measures rather than laissez-faire online markets.
Practical takeaways
- Don’t self-inject unregulated peptides. Evidence and safety are often absent; contamination and wrong dosing are real harms.
- If interested in medical or performance interventions, follow regulated clinical evidence and consult healthcare professionals.
- Policymakers could prioritize surveillance, enforcement on suppliers, and facilitating clinical research to clarify benefits/risks.
Chuck Norris obituary — third segment
- Profile/obituary of Chuck Norris (died aged 86): from a poor, itinerant childhood in Oklahoma and Texas, to military service (where he discovered martial arts), to becoming a world-class karate champion and a cultural icon.
- Norris’s public image blended martial-arts credibility, conservative values (later authoring Black Belt Patriotism), and meme-fueled pop-culture status (internet “Chuck Norris facts” casting him as an invincible figure).
- The obituary emphasizes his personal evolution from shy, poor boy to a symbolic, larger-than-life figure admired by many.
Overall episode takeaways
- Cuba: U.S. pressure has amplified deep, pre-existing economic dysfunction. The humanitarian pain is immediate and severe; political outcomes hinge on whether reforms are broad and meaningful or narrowly engineered to favor entrenched elites (or foreign business interests).
- Peptides: The wellness market’s new wave of self-experimentation is fueled by easy online access and social media hype; it poses real safety and public-health questions that regulators and clinicians are only partly addressing.
- The episode mixes geopolitics, public policy and cultural reporting — showing how external pressure, internal mismanagement, and unregulated markets can converge to produce fast, visible human consequences.
Recommended actions / further reading
- For Cuba watchers: track negotiations, fuel and tourism flows, remittance/investment policy changes, and humanitarian indicators (power, healthcare availability, food/wage purchasing power).
- For consumers/health professionals: avoid unregulated peptide use; demand better testing and clinical trials; advocate for clearer regulation of online vendors and social-media marketing.
- For context: read The Economist’s further coverage on Cuba’s economic reforms, Venezuelan ties, and U.S. sanctions policy; consult peer-reviewed literature before considering any novel biomedical intervention.